Physician profile
Eric J Straka
NPI 1336147735
$580.46
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $133.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $78.22 | 2019-2020 | |
| Amgen INC. | $71.47 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $68.59 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $52.75 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $49.65 | 2019 | |
| Novo Nordisk INC | $45.15 | 2019 | |
| Pfizer INC. | $40.71 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.58 | 2019 | |
| Glaxosmithkline, LLC. | $29.95 | 2020 | |
| Lilly USA, LLC | $24.49 | 2019 | |
| Horizon Therapeutics Plc | $19.42 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.06 | 2019 | |
| Sanofi Pasteur INC. | $14.27 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.12 | 2019 | |
| Amarin Pharma, INC. | $12.87 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Circassia INC. | $12.16 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Straka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.